Treximet® (sumatriptan/naproxen) – First-time generic
November 21, 2017 – Macoven Pharmaceuticals launched an authorized generic version of Pernix Therapeutics’ Treximet (sumatriptan/naproxen) 85 mg/500 mg tablets, for the acute treatment of migraine attacks with or without aura in adults and pediatric patients ≥ 12 years of age.
Top